Could BEP Reduce the Risk of Brain Metastasis in Testicular Cancer?
A post-hoc analysis found that brain metastases are more frequent in patients with advanced germ cell tumors who have received dose-dense chemotherapy compared with those administered the BEP regimen.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Bryant Furlow Tags: Genitourinary Cancers News Testicular Cancer Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Chemotherapy | Germ Cell Tumors | Neurology | Testicular Cancer